A Case of Balsalazide-Induced Limited Form of Granulomatosis with Polyangiitis with Bronchiolitis Obliterans Organizing Pneumonia-like Variant in Ulcerative Colitis / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 323-327, 2012.
Article
in English
| WPRIM
| ID: wpr-21409
ABSTRACT
5-Aminosalicylate agents are the main therapeutic agents for ulcerative colitis. Balsalazide is a prodrug of 5-aminosalicylate and has fewer side effects than the other 5-aminosalicylate agents. Pulmonary complications resembling granulomatosis with polyangiitis in ulcerative colitis are extremely rare. Here, we report a patient with ulcerative colitis on balsalazide presenting respiratory symptoms and multiple pulmonary nodules from a chest radiography that was pathologically diagnosed with a limited form of granulomatosis with polyangiitis with bronchiolitis obliterans organizing pneumonia-like variant. To our knowledge, this is the first report of a balsalazide-induced limited form of granulomatosis with polyangiitis with bronchiolitis obliterans organizing pneumonia-like variant.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Phenylhydrazines
/
Thorax
/
Ulcer
/
Bronchiolitis
/
Bronchiolitis Obliterans
/
Colitis, Ulcerative
/
Granulomatosis with Polyangiitis
/
Mesalamine
/
Multiple Pulmonary Nodules
Limits:
Humans
Language:
English
Journal:
Tuberculosis and Respiratory Diseases
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS